128. Use of New TB Diagnostics in Clinical Medicine
Session: Symposium: Update on TB Diagnostics and Treatment of Complex, Multidrug-Resistant TB
Friday, October 21, 2011: 8:45 AM
Room: 253ABC


Max Salfinger, MD, Florida Department of Health, Tallahassee, FL

1977 State Board: University of Basel School of Medicine, Switzerland 1986-1988 Sabbatical: University of Colorado Health Science Center, Denver Colorado/ National Jewish Center for Immunology & Respiratory Medicine, Denver, Colorado Dr. Salfinger is currently the Chief of the Florida Department of Health Bureau of Laboratories (Florida State Laboratory Director) and Acting Bureau Chief, Bureau of TB and Refugee Health (Florida State TB Controller). Prior to his current position, Dr. Salfinger was with the New York State Department of Health Wadsworth Center from 1992 to November 2006. He has trained more than 50 International Fogarty Fellows, School of Public Health Interns, and visiting scientists. He has published more than 100 articles and book chapters. Dr. Salfinger has a keen interest in public health leadership. Dr. Salfinger was instrumental in the development of the New York Fast Track for Tuberculosis Testing Program which received the ASTHO Vision Award – Achieving Excellence in Public Health Through Innovation in 1996. In addition, Dr. Salfinger was chair of the Association of Public Health Laboratories TB Steering Committee and is a member of the ATS/CDC/IDSA Writing Committee ‘Diagnostic Standards and Classification of Tuberculosis in Adults and Children’. Dr. Salfinger is a member of the Governing Body of A.G. Holley State Hospital in Lantana, Florida.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.